Prednisone Completed Phase 3 Trials for Demyelinating Polyneuropathy Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01349270Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg